Pharmaceutical company Web sites for health professionals should require only disclaimers -- Glaxo counsel.
Executive Summary
COMPANY WEB SITES FOR HEALTH PROFESSIONALS SHOULD NOT REQUIRE PASSWORDS, only disclaimers, Glaxo counsel Patricia Gaegler told the Drug Information Association annual meeting in Montreal June 23. "There has been some suggestion raised as to whether or not passwords should be required to help prevent consumers from being exposed to promotion that is intended for healthcare professionals," Gaegler noted. However, a password system would put a "tremendous burden on the pharmaceutical company to check out in fact that the information being supplied [for the password] is valid. Consumers could simply lie and say that they are healthcare professionals," Gaegler maintained.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth